A structural parametrization of the binding and folding energetics pre
viously developed in this laboratory accounts quantitatively for the b
inding of 13 HIV-1 protease inhibitors for which high-resolution struc
tures are available (A77003, A78791, A76928, A74704, A76889, VX478, SB
203386, SB203238, SB206343, U100313, U89360, A98881, CGP53820). The bi
nding free energies for the inhibitors are predicted with a standard d
eviation of +/-1.1 kcal/mol or +/-10%. Furthermore, the formalism corr
ectly predicts the observed change in inhibition constant for the comp
lex of A77003 and the resistant protease mutant V82A, for which the hi
gh-resolution structure is also available. The analysis presented here
provides a structural mapping of the different contributions to the b
inding energetics. Comparison of the binding map with the residue stab
ility map indicates that the binding pocket in the protease molecule h
as a dual character: half of the binding site is defined by the most s
table region of the protein, while the other half is unstructured prio
r to inhibitor or substrate binding. This characteristic of the bindin
g site accentuates cooperative effects that permit mutations in distal
residues to have a significant effect on binding affinity. These resu
lts permit an initial assessment of the effects of mutations on the ac
tivity of protease inhibitors.